MedInvent

Executive Summary

MedInvent Ltd. is a UK-based medical device company dedicated to improving maternal healthcare outcomes, specifically by reducing obstetric anal sphincter injuries (OASIS) during childbirth. Founded in 2015, the company developed the EPISCISSORS-60™, a precision instrument designed to perform mediolateral episiotomies at the recommended 60-degree angle. This guideline-aligned tool addresses a critical gap in current practices, where improper episiotomy angles contribute to severe perineal trauma. MedInvent's focus on a single, clinically impactful product positions it as a niche player in the maternal health market, with potential to reduce healthcare costs and improve quality of life for mothers worldwide. While the company is private and early-stage, its targeted solution and alignment with clinical guidelines suggest a clear value proposition for hospitals and birth centers seeking to minimize litigation risks and enhance patient outcomes.

Upcoming Catalysts (preview)

• Q3 2026CE Mark Renewal or Expanded Approval85% success
• Q4 2026Publication of Clinical Study on OASIS Reduction70% success
• H1 2027First Major Distribution Partnership (e.g., NHS Trust)50% success